Aerie Pharmaceuticals hires former Allergan, Alcon exec to help lead clinical, medical affairs

Michelle Senchyna, Ph.D., has been named as the new vice president for clinical development and medical affairs at eye disorder biotech Aerie Pharmaceuticals.

Senchyna will “lead and direct the clinical development and medical affairs strategy for the company,” it said in a statement, and comes off a stint as executive director of ophthalmology at Allergan, having also worked at Alcon and Panoptica.